Marico Limited (MARICO) AI Stock Analysis

• Market Cap: ₹944.05B
• Dividend Yield: 1.45%
• Average Volume (3M): 43.30K
• Price to Earnings (P/E): 57.0
• Beta (1Y): 0.49
• Revenue Growth: 16.58%
• EPS Growth: 9.72%
• Country: IN
• Employees: 1,834
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Household & Personal Products
• EPS (TTM): 3.90
• Shares Outstanding: 1,297,935,700
• 10 Day Avg. Volume: 38,273
• 30 Day Avg. Volume: 43,297
• PEG Ratio: 5.23
• Price to Book (P/B): 21.13
• Price to Sales (P/S): 7.75
• P/FCF Ratio: 69.87
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ₹815.25
• Price Target Upside: 12.95% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 8

• Rating: 69 Neutral
• Price Target: ₹795.00 ▲(10.14% Upside)

Marico Limited's strong financial performance is the most significant factor, supported by solid revenue and profit growth and efficient management. Technical analysis shows a positive trend, though short-term indicators suggest caution. The high P/E ratio indicates a premium valuation, which may limit upside potential. Overall, the stock is well-positioned but may face valuation challenges.

Marico Limited Business Overview & Revenue Model

Company Description

Marico Limited, together with its subsidiaries, manufactures and markets consumer products. It offers coconut oils, hair oils, refined edible oils, anti-lice treatments, fabric care, immunity boosting and healthy foods, hair gels, hair serums, shampoos, hair creams and conditioners, deodorants, body lotion and gels, shower gels, hair relaxers and straighteners, fabric care, baby care, and skin care and male grooming products, as well as hygiene products. The company markets its products under the Parachute, Parachute Advansed, Nihar Naturals, Saffola, Saffola FITTIFY Gourmet, Saffola Immuniveda, Hair & Care, Coco Soul, Beardo, Just Herbs, Revive, Mediker, Livon, and Set-wet brand names in India; and under the Parachute, Parachute Advansed, Fiancée, Hair Code, Caivil, Hercules, Black Chic, Code 10, Ingwe, X-men, Mediker SafeLife, Isoplus, and Thuan Phat brand names internationally. Its distribution network comprises regional offices, carrying and forwarding agents, redistribution centers, and distributors. The company was incorporated in 1988 and is headquartered in Mumbai, India.

How the Company Makes Money

Marico generates revenue primarily through the sale of its consumer products across multiple categories. The company's key revenue streams include the sale of hair oils, which is one of its largest segments, as well as health foods and cooking oils. Marico employs a multi-channel distribution strategy, leveraging both traditional retail and modern trade formats to reach consumers effectively. Additionally, the company has expanded its footprint in international markets, contributing to its revenue growth through exports and local operations. Strategic partnerships with distributors and retailers enhance its market reach, while continuous product innovation and marketing efforts help to strengthen brand loyalty and drive sales.

Marico Limited Financial Statement Overview

Summary

Marico Limited shows strong financial performance with robust revenue and profit growth, efficient operational management, and a solid balance sheet with low leverage. Despite minor fluctuations in cash flow growth, the company maintains a strong financial foundation.

Income Statement

Marico Limited demonstrated strong financial performance with a consistent increase in total revenue over the years, achieving a revenue growth rate of 12.21% in 2025. The company maintains a healthy gross profit margin of 50.26% and a net profit margin of 15.04% in 2025, reflecting robust profitability. The EBIT margin improved to 32.16%, and the EBITDA margin is at 19.75%, indicating efficient operational management. Overall, the income statement shows a positive growth trajectory and strong profitability.

Balance Sheet

The balance sheet of Marico Limited reflects a stable financial position with a debt-to-equity ratio of 0.14, indicating low leverage risk. The return on equity (ROE) stands at 40.98%, showcasing effective utilization of equity to generate profits. The equity ratio is 47.67%, suggesting a balanced capital structure with a strong equity base. However, the modest increase in stockholders’ equity suggests room for improvement in asset growth.

Cash Flow

Marico Limited's cash flow statement highlights a strong cash position, with positive free cash flow and a free cash flow to net income ratio of 0.74 in 2025, indicating efficient cash generation relative to profits. The company maintains a healthy operating cash flow to net income ratio of 0.84, demonstrating effective conversion of profits into cash. Despite a dip in free cash flow growth, the overall cash flow situation remains robust, supporting the company's operational and investment activities.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	114.47B	108.31B	95.73B	97.64B	94.52B	79.91B
Gross Profit	55.91B	54.43B	45.63B	44.13B	37.47B	34.63B
EBITDA	23.41B	21.39B	21.67B	19.53B	17.76B	16.97B
Net Income	16.69B	16.29B	14.81B	13.02B	12.25B	11.72B
Balance Sheet
Total Assets	0.00	83.38B	74.21B	69.46B	57.86B	55.10B
Cash, Cash Equivalents and Short-Term Investments	21.50B	21.52B	12.01B	13.38B	12.18B	15.07B
Total Debt	0.00	5.54B	5.28B	6.08B	4.79B	5.10B
Total Liabilities	-42.66B	40.72B	32.52B	29.90B	23.81B	22.52B
Stockholders Equity	42.66B	39.75B	38.32B	37.99B	33.48B	32.40B
Cash Flow
Free Cash Flow	0.00	12.02B	12.83B	12.37B	8.84B	19.26B
Operating Cash Flow	0.00	13.63B	14.36B	14.19B	10.16B	20.68B
Investing Cash Flow	0.00	-6.21B	1.76B	-8.65B	4.25B	-9.38B
Financing Cash Flow	0.00	-6.49B	-15.42B	-5.60B	-12.90B	-10.58B

Marico Limited Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 721.80
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:MARICO, the sentiment is Positive. The current price of 721.8 is above the 20-day moving average (MA) of 716.85, above the 50-day MA of 721.30, and above the 200-day MA of 687.38, indicating a bullish trend. The MACD of 2.13 indicates Negative momentum. The RSI at 52.54 is Neutral, neither overbought nor oversold. The STOCH value of 43.32 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:MARICO.

Marico Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
TATACONSUM	―	₹1.15T	86.64	―	0.70%	14.09%	13.85%
MARICO	―	₹944.05B	57.02	―	1.45%	16.58%	9.72%
DABUR	―	₹902.10B	50.61	―	1.58%	-0.03%	-5.22%
COLPAL	―	₹610.27B	44.81	―	2.26%	-2.06%	-9.74%
Sector *	―	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
GODREJAGRO	―	₹127.09B	27.79	―	1.65%	2.61%	16.80%
GODREJIND	―	₹365.92B	36.29	―	―	21.58%	393.14%

Marico Limited Corporate Events

Marico Limited Receives ‘Very Good’ ESG Rating

Marico Limited has been assigned an ESG score of ’77’, indicating a ‘Very Good’ rating by CFC Finlease Private Limited, an independent ESG rating provider. This rating reflects positively on Marico’s environmental, social, and governance practices, potentially enhancing its reputation and attractiveness to investors focused on sustainability.

Marico Limited Faces FSSAI Penalty for Misbranding

Marico Limited has disclosed a penalty of Rs. 1,00,000 imposed by the Food Safety and Standards Authority of India (FSSAI) for alleged misbranding of some product samples in 2016. Despite this penalty, the company states that there is no significant impact on its financials or operations, and it reserves the right to appeal the order.

Marico Limited Submits SEBI Compliance Certificate for Q3 2025

Marico Limited has submitted a compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ending September 30, 2025. The certificate, issued by MUFG Intime India Private Limited, confirms that securities received for dematerialization were processed and listed appropriately, ensuring regulatory compliance and maintaining the integrity of Marico’s securities management.

Marico Limited Faces Income Tax Department Visits

Marico Limited has reported that the Income Tax Department conducted visits to some of its offices and manufacturing units in India. The company is cooperating fully with the authorities and has stated that there is currently no material impact on its business operations. Marico has assured stakeholders that any further significant updates will be disclosed in compliance with regulatory requirements.

Marico Releases Q1 2025 Earnings Call Recording

Marico Limited announced the availability of the audio recording of its earnings conference call for the quarter ended June 30, 2025, on its website. This update provides stakeholders with insights into the company’s financial performance and operations, enhancing transparency and communication with investors.

Marico Limited Announces Intra-Group Restructuring to Enhance Digital Strategy

Marico Limited has announced an intra-group restructuring as part of its digital-first strategy, integrating its subsidiary Apcos Naturals Private Limited, known for the ‘Just Herbs’ brand, into the parent company. This move aims to enhance operational synergies, optimize costs, and streamline the corporate structure, with no material impact on the company’s consolidated financials, as Apcos contributes only 0.91% to the overall turnover.

Marico Limited Releases Q1 FY26 Financial Results

Marico Limited has released its un-audited consolidated financial results for the quarter ending June 30, 2025. The results, which are available on the company’s website, provide stakeholders with insights into the company’s financial performance during this period. This update is crucial for investors and analysts as it reflects Marico’s operational health and strategic positioning in the consumer goods market.